Business Responsibility and Sustainability Report for the financial year 2025-26

Ref: MHL/Sec&Legal/2026-27/25 July 27, 2026 BSE Limited National Stock Exchange of India Limited Scrip Code: 542650 Scrip Symbol: METROPOLIS Dear Sir/Madam, Sub: Business Responsibility and Sustainability Report for the financial year 2025-26 Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Business Responsibility and Sustainability Report for the financial year 2025-26, which also forms part of the Annual Report for the financial year 2025-26. You are requested to take the above information on record. Thanking you, Yours faithfully, For Metropolis Healthcare Limited Kamlesh C Kulkarni Head – Legal & Secretarial Encl: a/a Metropolis Healthcare Limited Corporate Overview Statutory Reports Financial Statements Business Responsibility and Sustainability Report (BRSR) 2025-26 SECTION A- GENERAL DISCLOSURES I. Details of the listed entity 1. Corporate Identity Number (CIN) of the listed entity: L73100MH2000PLC192798 2. Name of the listed entity: Metropolis Healthcare Limited 3. Year of incorporation: 10/11/2000 4. Registered office address: Metropolis Healthcare Limited, 4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai - 400030, Maharashtra, India 5. Corporate address: Metropolis Healthcare Limited, 4th Floor, Commercial Building 1A, Kohinoor Mall, Vidyavihar, (West), Mumbai - 400070, Maharashtra, India. 6. E-mail: secretarial@metropolisindia.com 7. Telephone: 022 6258 2898 8. Website: www.metropolisindia.com 9. Financial year for which reporting is being done: Financial Year 2025-26 10. Name of the Stock Exchange(s) where shares are listed: National Stock Exchange of India Ltd. and Bombay Stock Exchange (BSE) Limited 11. Paid-up Capital: `4146.55 Lakh 12. Name and contact details (telephone, email address) of the person who may be contacted in case of any queries on the BRSR report. Mr. Kamlesh Kulkarni, Company Secretary and Compliance Officer, Metropolis Healthcare Limited Email ID: secretarial@metropolisindia.com; Telephone: 022 6258 2898. 13. Reporting boundary - Are the disclosures under this report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together). - Standalone basis. 14. Name of assurance provider Not Applicable 15. Type of assurance obtained Not Applicable II. Products/services 16. Details of business activities (accounting for 90% of the turnover): Sr. % of Turnover of the Description of Main Activity Description of Business Activity No. entity 1. Human health and social work Diagnostic testing service provider, Soft radiology 100 activities services (ECG, X-ray etc), and Clinical Trial Research Services Annual Report 2025-26 Business Responsibility and Sustainability Report (Contd.) 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): Sr. Product/Service NIC Code % of total Turnover No. contributed 1. Diagnostic testing service provider, Soft radiology services 86905 100 (ECG, X-ray etc), and Clinical Trial Research Services III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of Plants Number of Offices Total National 0 212 212 International 0 5 5 Remark: The total number of offices refers to the 212 laboratories operated by Metropolis. 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) 28 States and 7 Union Territories International (No. of Countries) 21* *International Markets Served: Metropolis operates offices and laboratories across five African countries—Kenya, Zambia, Ghana, Tanzania, and Uganda. In addition, the Company serves a diverse portfolio of B2B laboratory clients across 16 international markets, including the UAE (Dubai and Abu Dhabi), Oman, and Qatar in the Middle East; Bangladesh, Nepal, Sri Lanka, the Maldives, Uzbekistan, and Vietnam in Asia; and Mauritius, Nigeria, the Congo, Cameroon, Sierra Leone, and Zimbabwe in Africa. b. What is the contribution of exports as a percentage of the total turnover of the entity? 3.31% c. A brief on types of customers Metropolis serves a diverse customer base including B2C (direct-to-consumer diagnostics via centres, app, website, and home collection), B2B (partnerships with standalone labs, hospital chains, and diagnostic networks), and institutional clients (corporates, government bodies, and hospital lab management services). IV. Employees 20. Details as at the end of Financial Year a. Employees and workers (including differently abled): No Particulars Total(A) Male Female No(B) %(B/A) No(C) %(C/A) Employees 1 Permanent (D) 3279 2112 64.41% 1167 35.59% 2 Other than Permanent (E) 299 127 42.47% 172 57.53% 3 Total employees (D + E) 3578 2239 62.58% 1339 37.42% Workers 1 Permanent (F) 1205 488 40.50% 717 59.50% 2 Other than Permanent (G) 61 38 62.30% 23 37.70% 3 Total Workers (F + G) 1266 526 41.55% 740 58.45% Metropolis Healthcare Limited Corporate Overview Statutory Reports Financial Statements Business Responsibility and Sustainability Report (Contd.) b. Differently abled Employees and workers: No Particulars Total(A) Male Female No(B) %(B/A) No(C) %(C/A) Differently Abled Employees 1 Permanent (D) 3 3 100% - - 2 Other than Permanent (E) - - - - - 3 Total differently abled employees (D + E) 3 3 100% - - Differently Abled Workers 1 Permanent (F) - - - - - 2 Other than Permanent (G) - - - - - 3 Total Workers (F + G) - - - - - 21. Participation/Inclusion/Representation of women Particulars Total(A) No. and percentage of Females No(B) %(B/A) Board of Directors 10 3 30.00% Key Management Personnel 4 1 25.00% 22. Turnover rate for permanent employees and workers. (Disclose trends for the past 3 years) FY 2025-26 FY 2024-25 FY 2023-24 Particulars Male Female Total Male Female Total Male Female Total Permanent Employees 10.6% 9.5% 10.2% 18.56% 14.45% 17.19% 15% 15% 15% Permanent Workers 14.3% 18.2% 16.6% 21.68% 23.20% 22.54% 36% 28% 32% V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. (a) Names of holding / subsidiary / associate companies / joint ventures. Sr. Name of the holding / subsidiary / Indicate whether % of Does the entity indicated No. associate companies / joint ventures holding/ subsidiary/ shares at column A, participate in (A) associate/ joint held by the Business Responsibility venture listed initiatives of the listed entity entity? (Yes/No) 1 Amin’s Pathology Laboratory Private Subsidiary 100 No Limited 2 Ekopath Metropolis Lab Services Subsidiary 60 No Private Limited 3 Centralab Healthcare Services Private Subsidiary 100 No Limited 4 DAPIC Metropolis Healthcare Private Subsidiary 100 No Limited (formerly known as Metropolis Histoxpert Digital Services Private Limited) 5 Metropolis Foundation Subsidiary 100 No 6 Scientific Metropolis Pathology Private Subsidiary 90 No Limited (formerly known as Metropolis Clinical Pathology Private Limited) 7 Core Diagnostics Private Limited Subsidiary 100 No 8 Metropolis Quality Solutions Private Subsidiary 100 No Limited 9 Metropolis Healthcare (Mauritius) Subsidiary 100 No Limited 10 Metropolis Star Lab Kenya Limited Subsidiary 100 No Annual Report 2025-26 Business Responsibility and Sustainability Report (Contd.) Sr. Name of the holding / subsidiary / Indicate whether % of Does the entity indicated No. associate companies / joint ventures holding/ subsidiary/ shares at column A, participate in (A) associate/ joint held by the Business Responsibility venture listed initiatives of the listed entity entity? (Yes/No) 11 Metropolis Healthcare Ghana Limited Subsidiary 100 No 12 Metropolis Healthcare Lanka Private Subsidiary 100 No Limited 13 Metropolis Healthcare (Tanzania) Subsidiary 99.99 No Limited 14 Metropolis Healthcare Uganda Limited Subsidiary 100 No 15 Metropolis Bramser Lab Services [Showing first 8,000 characters — download PDF for full document]